Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2023
2023-12-22 15:48
BioStock publishes CEO comments on the outcome of the rights issue
2023-12-20 08:00
Prolight announces outcome in the rights issue
Regulatory
MAR
2023-12-15 14:30
Prolight's board and management increase their shareholdings
Regulatory
2023-12-07 11:45
BioStock publishes rights issue article about Prolight Diagnostics
2023-12-04 11:20
BioStock publishes article regarding Prolight Diagnostics rights issue
2023-12-04 08:00
The subscription period in Prolight Diagnostics AB (publ) rights issue of units starts today
Regulatory
2023-11-28 17:22
Prolight Diagnostics AB (publ) publishes prospectus in connection with rights issue of units
Regulatory
2023-11-28 13:40
BioStock publishes article about Prolight Diagnostics
2023-11-27 15:05
Prolight Diagnostics publishes quarterly report Q3, 2023
Regulatory
MAR
2023-11-27 12:45
Extraordinary general meeting of Prolight Diagnostics AB (publ) on 27 November 2023
Regulatory
Previous
Next
